Location History:
- Durham, NH (US) (1986)
- Clifton, NJ (US) (2001)
- Fort Myers, FL (US) (2006)
- Old Forge, NY (US) (2006)
Company Filing History:
Years Active: 1986-2006
Title: The Innovative Contributions of Louise H. Foley
Introduction
Louise H. Foley is a prominent inventor based in Fort Myers, FL (US), known for her significant contributions to the field of pharmaceuticals. With a total of 5 patents to her name, she has made remarkable strides in the development of compounds that modulate gluconeogenesis.
Latest Patents
Among her latest patents is the invention of sulfonamide substituted xanthine derivatives. This invention presents a sulfonamide substituted xanthine derivative of formula I, or a pharmaceutically acceptable salt thereof, where R1 is lower alkyl, lower alkyl substituted by phenyl, or lower alkyl substituted by halogen substituted phenyl. R2 is lower alkyl or lower alkyl substituted by lower cycloalkyl, and R3 is defined in the specification. Compounds of formula I and pharmaceutically acceptable salts or prodrugs thereof show activity as modulators of gluconeogenesis. Another notable patent is the amide substituted xanthine derivatives, which is a 1,3,8 substituted xanthine derivative of formula I, or a pharmaceutically acceptable salt thereof, with R, R, and R defined in the specification. Similar to her other inventions, these compounds also demonstrate activity as modulators of gluconeogenesis.
Career Highlights
Louise H. Foley is currently associated with Hoffmann-La Roche Inc., where she continues to innovate and contribute to the pharmaceutical industry. Her work has been instrumental in advancing the understanding and treatment of metabolic conditions.
Collaborations
Throughout her career, Louise has collaborated with notable professionals in her field, including Peter W. Dunten and Nicholas J. Huby. These collaborations have further enhanced her research and development efforts.
Conclusion
Louise H. Foley's innovative work in the pharmaceutical sector has led to significant advancements in the modulation of gluconeogenesis. Her contributions are invaluable, and her patents reflect her dedication to improving health outcomes through scientific innovation.